Evusheld has been heralded as a way to armor people who remain highly vulnerable to COVID-19 even after vaccination. As government officials loosen masking requirements that have helped shield the immunocompromised, the preventive treatment has gained even more urgency for people who do not generate enough antibodies to gain protection from the COVID-19 vaccines. Source: COVID-19 drug Evusheld for vulnerable people can be hard to get – Los Angeles Times